Have a feature idea you'd love to see implemented?
Let us know!
SNTI Senti Biosciences Inc.
Price (delayed)
$2.14
Market cap
$9.8M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$12.65
Enterprise value
$26.13M
Highlights
SNTI's net income is up by 21% YoY and by 12% from the previous quarter
SNTI's EPS is up by 13% year-on-year and by 12% since the previous quarter
SNTI's gross profit has dropped by 92% year-on-year and by 73% since the previous quarter
The revenue has plunged by 92% YoY and by 73% from the previous quarter
Key stats
What are the main financial stats of SNTI
Market
Valuations
Earnings
Shares outstanding
4.58M
Market cap
$9.8M
Enterprise value
$26.13M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.22
Price to sales (P/S)
28.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
77.32
Revenue
$338,000
EBIT
-$56.95M
EBITDA
-$50.74M
Free cash flow
-$44.22M
Per share
Balance sheet
Liquidity
EPS
-$12.65
Free cash flow per share
-$9.67
Book value per share
$9.65
Revenue per share
$0.07
TBVPS
$19.01
Total assets
$86.91M
Total liabilities
$42.77M
Debt
$35.74M
Equity
$44.15M
Working capital
$35.27M
Debt to equity
0.81
Current ratio
4.89
Quick ratio
2.14
Net debt/EBITDA
-0.32
Margins
Efficiency
Dividend
EBITDA margin
-15,010.7%
Gross margin
100%
Net margin
-16,850%
Operating margin
-27,287.3%
Return on assets
-51.7%
Return on equity
-91.1%
Return on invested capital
-55%
Return on capital employed
-73.2%
Return on sales
-16,850%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNTI stock price
How has the Senti Biosciences stock price performed over time
Intraday
-7.36%
1 week
-0.47%
1 month
-26.96%
1 year
-30.52%
YTD
-67.58%
QTD
-5.31%
Financial performance
How have Senti Biosciences's revenue and profit performed over time
Revenue
$338,000
Gross profit
$338,000
Operating income
-$92.23M
Net income
-$56.95M
Gross margin
100%
Net margin
-16,850%
SNTI's gross profit has dropped by 92% year-on-year and by 73% since the previous quarter
The revenue has plunged by 92% YoY and by 73% from the previous quarter
SNTI's operating income is down by 49% year-on-year
SNTI's net income is up by 21% YoY and by 12% from the previous quarter
Growth
What is Senti Biosciences's growth rate over time
Valuation
What is Senti Biosciences stock price valuation
P/E
N/A
P/B
0.22
P/S
28.95
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
77.32
SNTI's EPS is up by 13% year-on-year and by 12% since the previous quarter
Senti Biosciences's equity has shrunk by 55% YoY and by 21% QoQ
SNTI's P/B is 27% below its last 4 quarters average of 0.3
The revenue has plunged by 92% YoY and by 73% from the previous quarter
The P/S is 67% more than the last 4 quarters average of 17.3
Efficiency
How efficient is Senti Biosciences business performance
The ROE has plunged by 50% YoY and by 7% from the previous quarter
The ROA has contracted by 21% YoY
The ROIC is up by 3.8% since the previous quarter and by 2.8% year-on-year
Dividends
What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNTI.
Financial health
How did Senti Biosciences financials performed over time
The company's total assets is 103% higher than its total liabilities
The quick ratio has dropped by 65% year-on-year and by 26% since the previous quarter
The company's total assets fell by 39% YoY and by 15% QoQ
The debt is 19% less than the equity
SNTI's debt to equity has surged by 108% year-on-year and by 25% since the previous quarter
Senti Biosciences's equity has shrunk by 55% YoY and by 21% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.